During the past decade, Lyndon Baines Johnson General Hospital conducted 44 clinical trials. In the 10-year time frame, 44 clinical trials started and 44 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 28 clinical trials were completed. i.e. 350% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Lyndon Baines Johnson General Hospital" #1 sponsor was "M.D. Anderson Cancer Center" with 47 trials, followed by "The University of Texas Health Science Center, Houston" with 20 trials sponsored, "National Cancer Institute (NCI)" with 16 trials sponsored, "SWOG Cancer Research Network" with 10 trials sponsored and "Gynecologic Oncology Group" with 10 trials sponsored. Other sponsors include 7 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Lyndon Baines Johnson General Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 48 trials as a collaborator, "NRG Oncology" with 10 trials as a collaborator, "American Cancer Society, Inc." with 3 trials as a collaborator, "Genentech, Inc." with 3 trials as a collaborator and "Canadian Cancer Trials Group" with 2 trials as a collaborator. Other collaborators include 19 different institutions and companies that were collaborators in the rest 27 trials.

According to Clinical.Site data, the most researched conditions in "Lyndon Baines Johnson General Hospital" are "Cervical Cancer" (11 trials), "Cervical Adenocarcinoma" (8 trials), "Ovarian Endometrioid Adenocarcinoma" (8 trials), "Fallopian Tube Clear Cell Adenocarcinoma" (7 trials) and "Fallopian Tube Endometrioid Adenocarcinoma" (7 trials). Many other conditions were trialed in "Lyndon Baines Johnson General Hospital" in a lesser frequency.

Most popular intervention types in "Lyndon Baines Johnson General Hospital" are "Drug" (68 trials), "Other" (48 trials), "Behavioral" (27 trials), "Procedure" (26 trials) and "Biological" (12 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (27 trials), "Quality-of-Life Assessment" (17 trials), "Paclitaxel" (13 trials), "Carboplatin" (10 trials) and "Questionnaire" (9 trials). Other intervention names were less common.

The vast majority of trials in "Lyndon Baines Johnson General Hospital" are 58 trials for "All" genders, 49 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Lyndon Baines Johnson General Hospital". 2 are not yet recruiting, 10 are recruiting, 27 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 52 completed trials in Lyndon Baines Johnson General Hospital, undefined suspended trials, and 11 terminated clinical trials to date.

Out of the total trials that were conducted in Lyndon Baines Johnson General Hospital, 4 "Phase 1" clinical trials were conducted, 36 "Phase 2" clinical trials and 30 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 18 trials that are defined as “Not Applicable".